» Articles » PMID: 21270732

Cross-coupling Reactions As Valuable Tool for the Preparation of PET Radiotracers

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2011 Jan 29
PMID 21270732
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The increasing application of positron emission tomography (PET) in nuclear medicine has stimulated the extensive development of a multitude of new radiotracers and novel radiolabeling procedures with the most prominent short-lived positron emitters carbon-11 and fluorine-18. Radiolabeling with these radionuclides represents a remarkable challenge. Special attention has to be paid to synthesis time and specific labeling techniques due to the short physical half life of the respective radionuclides ¹¹C (t(½) = 20.4 min) and ¹⁸F (t½) = 109.8 min). In the past, numerous transition metal-catalyzed reactions were employed in organic chemistry, even though only a handful of these coupling reactions were adopted in radiochemical practice. Thus, the implementation of modern synthesis methods like cross-coupling reactions offers the possibility to develop a wide variety of novel radiotracers. The introduction of catalysts based on transition metal complexes bears a high potential for rapid, efficient, highly selective and functional group-tolerating incorporation of carbon-11 and fluorine-18 into target molecules. This review deals with design, application and improvement of transition metal-mediated carbon-carbon as well as carbon-heteroatom cross-coupling reactions as a labeling feature with the focus on the preparation of radiolabeled compounds for molecular imaging.

Citing Articles

Synthesis and Characterization of a New Carbon-11 Labeled Positron Emission Tomography Radiotracer for Orexin 2 Receptors Neuroimaging.

Wang Y, Wang Y, Liu Y, Cheng H, Dagnew T, Xu Y Drug Des Devel Ther. 2024; 18:215-222.

PMID: 38312991 PMC: 10838518. DOI: 10.2147/DDDT.S404992.


F-Radiolabeled Translocator Protein (TSPO) PET Tracers: Recent Development of TSPO Radioligands and Their Application to PET Study.

Luu T, Kim H Pharmaceutics. 2022; 14(11).

PMID: 36432736 PMC: 9697781. DOI: 10.3390/pharmaceutics14112545.


Silicon compounds in carbon-11 radiochemistry: present use and future perspectives.

Luzi F, Gee A, Bongarzone S Org Biomol Chem. 2021; 19(32):6916-6925.

PMID: 34319335 PMC: 8372417. DOI: 10.1039/d1ob01202a.


Synthesis of Fluorinated Alkyl Aryl Ethers by Palladium-Catalyzed C-O Cross-Coupling.

Szpera R, Isenegger P, Ghosez M, Straathof N, Cookson R, Blakemore D Org Lett. 2020; 22(16):6573-6577.

PMID: 32806200 PMC: 7458480. DOI: 10.1021/acs.orglett.0c02347.


Copper(I)-Mediated C-Carboxylation of (Hetero)arylstannanes.

Duffy I, Vasdev N, Dahl K ACS Omega. 2020; 5(14):8242-8250.

PMID: 32309734 PMC: 7161067. DOI: 10.1021/acsomega.0c00524.


References
1.
Mangner T, Klecker R, Anderson L, Shields A . Synthesis of 2'-deoxy-2'-[18F]fluoro-beta-D-arabinofuranosyl nucleosides, [18F]FAU, [18F]FMAU, [18F]FBAU and [18F]FIAU, as potential PET agents for imaging cellular proliferation. Synthesis of [18F]labelled FAU, FMAU, FBAU, FIAU. Nucl Med Biol. 2003; 30(3):215-24. DOI: 10.1016/s0969-8051(02)00445-6. View

2.
Iida Y, Ogawa M, Ueda M, Tominaga A, Kawashima H, Magata Y . Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors. J Nucl Med. 2004; 45(5):878-84. View

3.
Toyohara J, Okada M, Toramatsu C, Suzuki K, Irie T . Feasibility studies of 4'-[methyl-(11)C]thiothymidine as a tumor proliferation imaging agent in mice. Nucl Med Biol. 2007; 35(1):67-74. DOI: 10.1016/j.nucmedbio.2007.10.001. View

4.
Sandell J, Halldin C, Sovago J, Chou Y, Gulyas B, Yu M . PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nucl Med Biol. 2002; 29(6):651-6. DOI: 10.1016/s0969-8051(02)00318-9. View

5.
Giardina G, Sarau H, Farina C, Medhurst A, Grugni M, FOLEY J . 2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. J Med Chem. 1996; 39(12):2281-4. DOI: 10.1021/jm9602423. View